| 【1】Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. PMID: 23732715.【2】Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM. Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1211-F1217. PMID: 30864840.【3】MacDonald TT, Monteleone I, Fantini MC, et al. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011 May;140(6):1768-75. PMID: 21530743.【4】Meijers BK, Evenepoel P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant. 2011 Mar;26(3):759-61. PMID: 21343587.【5】Vaziri ND, Suematsu Y, Shimomura A, et al. Uremic toxins and gut micro biome. Nihon Jinzo Gakkai Shi. 2017;59(4):535-544. Japanese. PMID: 30620802.【6】Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013;37(1):1-6. PMID: 23258127.【7】邢晓辉,李力仙,郭天林,等.Occludin蛋白与细胞间紧密连接关系及其临床意义[J].现代生物医学进展,2015,15(08):1553-1555+1405.【8】 Zhang Z, Shi Y, Cai D, et al. Effect of electroacupuncture at ST36 on the intestinal mucosal mechanical barrier and expression of occludin in a rat model of sepsis. Acupunct Med. 2018 Oct;36(5):333-338. PMID: 30002000.【9】Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013;37(1):1-6. PMID: 23258127.【10】Shi K, Wang F, Jiang H, et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci. 2014 Sep;59(9):2109-17. PMID: 24828917.【11】 Mafra D, Fouque D. Gut microbiota and inflammation in chronic kidney diseasepatients[J]. Clinical Kidney Joumal, 2015, 8(3): 332-334【12】Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch. 2020 Mar;472(3):303-320. PMID: 32064574.【13】Wang JH, Kim BS, Han K, et al. Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats. Int J Environ Res Public Health. 2017 May 23;14(6):555. PMID: 28545248.【14】 Alessandri G, Milani C, Mancabelli L, et al. Metagenomic dissection of the canine gut microbiota: insights into taxonomic, metabolic and nutritional features. Environ Microbiol. 2019 Apr;21(4):1331-1343. PMID: 30680877.【15】Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013 Feb;83(2):308-15.PMID: 22992469.【16】Lassenius MI, Fogarty CL, Blaut M, et al. Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. J Intern Med. 2017 Jun;281(6):586-600. PMID: 28393441.【17】Mahalhal A, Williams JM, Johnson S, et al. Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS One. 2018 Oct 11;13(10):e0202460. PMID: 30308045.【18】韩渤,刘玥宏,仇志强,张子卿,王雪,徐敬东.SIgA表达功能及其在肠道疾病的作用[J].世界华人消化杂志,2017,25(19):1757-1763.【19】王尊松. 尿毒症患者肠粘膜屏障功能的研究[D].山东大学,2011.【20】Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant. 2016 May;31(5):737-46. PMID: 25883197.【21】贾佑铎,郭兆安.慢性肾衰竭消化系统症状发病机制及治疗研究新进展[J].中国中西医结合肾病杂志,2014,15(10):936-937.【22】刘钰,方敬爱.慢性肾衰竭患者微炎症的研究概况[J].世界最新医学信息文摘,2018,18(55):52-53.【23】Meng XM, Mak TS, Lan HY. Macrophages in Renal Fibrosis. Adv Exp Med Biol. 2019;1165:285-303. PMID: 31399970.【24】Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis. 2016 Oct;1(3):135-145. PMID: 29922669.【25】Putra AB, Nishi K, Shiraishi R, et al. Jellyfish collagen stimulates production of TNF-α and IL-6 by J774.1 cells through activation of NF-κB and JNK via TLR4 signaling pathway. Mol Immunol. 2014 Mar;58(1):32-7. PMID: 24291243.【26】Rahbar Saadat Y, Niknafs B, Hosseiniyan Khatibi SM, et al. Gut microbiota; an overlooked effect of phosphate binders. Eur J Pharmacol. 2020 Feb 5;868:172892. PMID: 31870830.【27】Stinghen AE, Pecoits-Filho R. Vascular damage in kidney disease: beyond hypertension. Int J Hypertens. 2011;2011:232683. PMID: 21876786.【28】Noh H, Yu MR, Kim HJ,et al.Beta 2-adrenergic receptor agonists arenovel regulators ofmacrophage activationindiabeticrenal and cardiovascularcomplications. Kidney Int 2017;92:101–113【29】李倩玉,周江慧,李娜,孙钰,刘锋.肠源性尿毒症毒素在肾脏病领域的研究进展[J].中国实验诊断学,2019,23(03):561-563.【30】Lekawanvijit S. Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities. Circ [J]. 2015;79(10):2088-97.PMID: 26346172.【31】Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators Inflamm. 2020 Feb 17;2020:4634172. PMID: 32148438.【32】方敬爱.从中西医结合的角度探讨结肠透析治疗慢性肾脏病[J].中国中西医结合杂志,2019,39(07):773-775.【33】He HD, Hu P, Chen X, et al. Npt2b plays a major role in hosphorus transportation and homeostasis in colon andsmall intestine of uremia patients［J］. Int J Clin ExpPathol,2016,9(12):12767-12772【34】龚奎,孔薇.中药结肠透析在慢性肾脏病中的临床研究进展[J].四川中医,2017,35(12):221-223.【35】周刊,吕冬宁,曾海飞.中药结肠透析治疗慢性肾衰竭临床应用进展[J].广西中医药大学学报,2019,22(02):63-65.【36】伦恒忠. 慢性肾脏病进展中肠道菌群变化及粪菌移植对慢性肾衰小鼠的影响[D].山东大学,2019.【37】Wang IK, Wu YY, Yang YF, et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015;6(4):423-30. PMID: 25609654.【38】张发明,范志宁,季国忠.粪菌移植的概念、历史、现状和未来[中国内镜杂志,2012,(09):30-43【39】 Smith M, Kassam Z, Edelstein C, et al. Open Biome remains opento serve theity [J]. Nat Biotechnol, 2014, 32(9): 867-867medical commune【40】Vaziri ND, Yuan J, Khazaeli M, et al. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol. 2013;37(6):518-25. PMID: 23689670.【41】Yang CY, Tarng DC. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients. Nephrology (Carlton). 2018 Oct;23 Suppl 4:16-20. PMID: 30298666.【42】Smith PM, Howitt MR, Panikov N, et al.The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013 Aug 2;341(6145):569-73. PMID: 23828891.【43】Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res. 2016 May 1;202(1):225-34. PMID: 27083970.【44】Lehto M, Groop PH. The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders. Front Endocrinol (Lausanne). 2018 Sep 19;9:553. PMID: 30283404.【45】Melo AD, Silveira H, Bortoluzzi C, et al. Intestinal alkaline phosphatase and sodium butyrate may be beneficial in attenuating LPS-induced intestinal inflammation. Genet Mol Res. 2016 Oct 17;15(4). PMID: 27813594. |
